Please use this identifier to cite or link to this item:
doi:10.22028/D291-44497
Title: | Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age |
Author(s): | Böhm, Michael Butler, Javed Filippatos, Gerasimos Ferreira, João Pedro Pocock, Stuart J. Abdin, Amr Mahfoud, Felix Brueckmann, Martina Gollop, Nicholas D. Iwata, Tomoko Ponikowski, Piotr Wanner, Christoph Zannad, Faiez Packer, Milton Anker, Stefan D. |
Language: | English |
Title: | Journal of the American College of Cardiology : JACC |
Volume: | 80 |
Issue: | 1 |
Pages: | 1-18 |
Publisher/Platform: | Elsevier |
Year of Publication: | 2022 |
DDC notations: | 610 Medicine and health |
Publikation type: | Journal Article |
Abstract: | Empagliflozin reduces cardiovascular death (CVD) or heart failure (HF) hospitalization (HFH) in patients with HF and preserved ejection fraction. Treatment effects and safety in relation to age have not been studied. |
DOI of the first publication: | 10.1016/j.jacc.2022.04.040 |
URL of the first publication: | https://www.jacc.org/doi/10.1016/j.jacc.2022.04.040 |
Link to this record: | urn:nbn:de:bsz:291--ds-444977 hdl:20.500.11880/39730 http://dx.doi.org/10.22028/D291-44497 |
ISSN: | 0735-1097 |
Date of registration: | 26-Feb-2025 |
Faculty: | M - Medizinische Fakultät |
Department: | M - Innere Medizin |
Professorship: | M - Prof. Dr. Michael Böhm |
Collections: | SciDok - Der Wissenschaftsserver der Universität des Saarlandes |
Files for this record:
File | Description | Size | Format | |
---|---|---|---|---|
böhm-et-al-2022-empagliflozin-improves-outcomes-in-patients-with-heart-failure-and-preserved-ejection-fraction.pdf | 3,8 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License